This information is contained in Rosselkhoznadzor’s response to a parliamentary inquiry, which quotes RIA Novosti.
“Rosselkhoznadzor proposes to establish an obligation for the manufacturer to provide, no later than 14 days from the moment such a drug batch is introduced into civilian circulation, an expert opinion confirming compliance with quality requirements... If it is not received... circulation of the batch is suspended,” the letter says.
At present, the manufacturer is required to ensure that each batch of the drug meets the established quality requirements, but the mandatory submission of a separate expert opinion for each batch after it is released into circulation is not provided for under the proposed mechanism.
The Agriculture Ministry, in turn, warns that introducing total control over each batch could negatively affect import substitution, according to the response to the parliamentary inquiry. At the same time, the ministry does not object in principle to moving to batch-by-batch control, but believes it is necessary first to work out the financial and economic rationale for the initiative.



